Sun Pharma's generic Cymbalta gets tentative approval from FDA

11/28/2010 | Business Standard (India)

The FDA has issued tentative marketing approval for Sun Pharmaceutical Industries' duloxetine hydrochloride, a copy of Eli Lilly and Co.'s Cymbalta. The drug is used for treating generalized anxiety disorder, diabetic peripheral neuropathic pain and major depressive disorder. Sun will launch the generic product in 20-, 30- and 60-milligram capsules.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ